Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Head and Neck Neoplasms"" wg kryterium: Temat


Tytuł:
Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.
Autorzy:
Cheng Y; Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha, 410008, Hunan, China.; Clinical Research Center of Oral Major Diseases and Oral Health & Academician, Central South University, Changsha, 410008, Hunan, China.
Song Z; Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha, 410008, Hunan, China.; Clinical Research Center of Oral Major Diseases and Oral Health & Academician, Central South University, Changsha, 410008, Hunan, China.
Fang X; Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha, 410008, Hunan, China. .; Clinical Research Center of Oral Major Diseases and Oral Health & Academician, Central South University, Changsha, 410008, Hunan, China. .
Tang Z; Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha, 410008, Hunan, China. .; Clinical Research Center of Oral Major Diseases and Oral Health & Academician, Central South University, Changsha, 410008, Hunan, China. .
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2024 Apr 10; Vol. 16 (1), pp. 54. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/metabolism
Mouth Neoplasms*/drug therapy
Mouth Neoplasms*/genetics
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Polycomb Repressive Complex 2/genetics ; Polycomb Repressive Complex 2/metabolism ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Enhancer of Zeste Homolog 2 Protein/genetics ; Enhancer of Zeste Homolog 2 Protein/metabolism ; Epigenesis, Genetic ; DNA Methylation
Czasopismo naukowe
Tytuł:
CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC.
Autorzy:
Geyer F; Department of Oral and Maxillofacial Surgery, Klinikum Rechts der Isar der Technischen Universität München, 81675, Munich, Germany. .
Geyer M; Department of Oral and Maxillofacial Surgery, Klinikum Rechts der Isar der Technischen Universität München, 81675, Munich, Germany.
Reuning U; Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, 81675, Munich, Germany.
Klapproth S; Institute of Experimental Hematology, School of Medicine, Technische Universität München, 81675, Munich, Germany.
Wolff KD; Department of Oral and Maxillofacial Surgery, Klinikum Rechts der Isar der Technischen Universität München, 81675, Munich, Germany.
Nieberler M; Department of Oral and Maxillofacial Surgery, Klinikum Rechts der Isar der Technischen Universität München, 81675, Munich, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 09; Vol. 14 (1), pp. 8286. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/radiotherapy
Head and Neck Neoplasms*/complications
Papillomavirus Infections*
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Squamous Cell Carcinoma of Head and Neck/complications ; Prognosis ; Cell Line, Tumor ; Mi-2 Nucleosome Remodeling and Deacetylase Complex
Czasopismo naukowe
Tytuł:
Evaluation of a new score associated with acute kidney injury in patients treated with cisplatin based EXTREME regimen.
Autorzy:
Avry F; Centre Régional Hospitalier Universitaire de Tours, 2 Boulevard Tonnellé, Tours, 37000, France. .
Roseau C; Centre Régional Hospitalier d'Orléans, Orléans, France.
Leguay Z; Centre Régional Hospitalier d'Orléans, Orléans, France.
Brabant S; Département d'Information Médicale, Centre Hospitalier Régional, Orléans, France.
Ganea A; Centre Hospitalier Régional, Service de dialyse et de Néphrologie, Orléans, France.
Champeaux-Orange E; Centre Hospitalier Régional, Service d'Oncologie et de Radiothérapie, Orléans, France.
Priou V; Centre Régional Hospitalier d'Orléans, Orléans, France.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 02; Vol. 24 (1), pp. 405. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Acute Kidney Injury*/chemically induced
Acute Kidney Injury*/epidemiology
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/chemically induced
Humans ; Cisplatin ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Head and neck cancer of unknown primary: unveiling primary tumor sites through machine learning on DNA methylation profiles.
Autorzy:
Stark L; Department of Otolaryngology, Head and Neck Surgery, School of Medicine and Health, Technical University of Munich, Munich, Germany. .; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine and Health, Technical University of Munich, Munich, Germany. .
Kasajima A; Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Stögbauer F; Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Schmidl B; Department of Otolaryngology, Head and Neck Surgery, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Rinecker J; Department of Otolaryngology, Head and Neck Surgery, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Holzmann K; Department of Otolaryngology, Head and Neck Surgery, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Färber S; Department of Otolaryngology, Head and Neck Surgery, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Pfarr N; Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Steiger K; Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany.
Wollenberg B; Department of Otolaryngology, Head and Neck Surgery, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Partner Site Munich and German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Ruland J; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Center for Translational Cancer Research, TranslaTUM, Technical University of Munich, Munich, Germany.; Partner Site Munich and German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Winter C; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Center for Translational Cancer Research, TranslaTUM, Technical University of Munich, Munich, Germany.; Partner Site Munich and German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Wirth M; Department of Otolaryngology, Head and Neck Surgery, School of Medicine and Health, Technical University of Munich, Munich, Germany.; Partner Site Munich and German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2024 Mar 25; Vol. 16 (1), pp. 47. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms, Unknown Primary*/diagnosis
Neoplasms, Unknown Primary*/genetics
Neoplasms, Unknown Primary*/pathology
Head and Neck Neoplasms*/diagnosis
Head and Neck Neoplasms*/genetics
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
Humans ; DNA Methylation ; Machine Learning
Czasopismo naukowe
Tytuł:
Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study.
Autorzy:
Guan Z; Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Liu J; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, NO.1 Jianshedong Road, Zhengzhou, 450052, Henan, China.
Zheng L; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, NO.1 Jianshedong Road, Zhengzhou, 450052, Henan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 15; Vol. 14 (1), pp. 6304. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/radiotherapy
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/radiotherapy
Mouth Neoplasms*/genetics
Mouth Neoplasms*/radiotherapy
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Glucose
Czasopismo naukowe
Tytuł:
Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer.
Autorzy:
Yang F; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Yuan C; Department of Biostatistics and Bioinformatics, Rolling School of Public Health, Emory University, Atlanta, GA, 30322, USA.
Chen F; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Qin ZS; Department of Biostatistics and Bioinformatics, Rolling School of Public Health, Emory University, Atlanta, GA, 30322, USA.
Schmitt NC; Department of Otolaryngology, Emory University, Atlanta, GA, 30322, USA.
Lesinski GB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Teng Y; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA. .; Department of Oral Biology and Diagnostic Sciences, Georgia Cancer Center, Augusta University, Augusta, GA, 30912, USA. .; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, 30322, USA. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 12; Vol. 43 (1), pp. 76. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Papillomavirus Infections*/complications
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/metabolism
Animals ; Mice ; Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/metabolism ; Interleukin-6/metabolism ; Neoplasm Recurrence, Local/metabolism ; Killer Cells, Natural ; Receptors, CCR2/genetics ; Receptors, CCR2/metabolism
Czasopismo naukowe
Tytuł:
Successful microvascular surgery in patients with thrombophilia in head and neck surgery: a case series.
Autorzy:
Faber J; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Cologne, 50937, Cologne, Germany. .
Schuster F; Department of Anaesthesia and Critical Care, Donau-Isar-Klinikum, 94469, Deggendorf, Germany.
Hartmann S; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Brands RC; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Fuchs A; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Straub A; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Fischer M; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Müller-Richter U; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070, Würzburg, Germany.
Linz C; Department of Oral and Maxillofacial Plastic Surgery, University Hospital Cologne, 50937, Cologne, Germany.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Feb 28; Vol. 18 (1), pp. 119. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Free Tissue Flaps*/blood supply
Head and Neck Neoplasms*/complications
Head and Neck Neoplasms*/surgery
Thrombophilia*/complications
Thrombophilia*/drug therapy
Thrombosis*/etiology
Humans ; Male ; Anticoagulants/therapeutic use ; Postoperative Complications ; Retrospective Studies ; Middle Aged
Czasopismo naukowe
Tytuł:
Prognostic model for overall survival of head and neck cancer patients in the palliative phase.
Autorzy:
Hoesseini A; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands. .
Sewnaik A; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
van den Besselaar BN; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Zhang J; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
van Leeuwen N; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
Hardillo JA; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Baatenburg de Jong RJ; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Offerman MPJ; Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Pokaż więcej
Źródło:
BMC palliative care [BMC Palliat Care] 2024 Feb 24; Vol. 23 (1), pp. 54. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*
Head and Neck Neoplasms*/complications
Head and Neck Neoplasms*/therapy
Humans ; Squamous Cell Carcinoma of Head and Neck/therapy ; Prognosis ; Proportional Hazards Models
Czasopismo naukowe
Tytuł:
Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment.
Autorzy:
Ding Q; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Lin F; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Huang Z; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Li Y; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Cai S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Chen X; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
Liu H; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China. .; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China. .
Qiu S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China. .; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 23; Vol. 14 (1), pp. 4426. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Cell Adhesion Molecules*/genetics
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
MicroRNAs*/genetics
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Humans ; Biomarkers ; Down-Regulation ; Prognosis ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology
Czasopismo naukowe
Tytuł:
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome.
Autorzy:
Broghammer F; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Korovina I; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany.
Gouda M; Department of Otorhinolaryngology, Head and Neck Surgery, Ludwigs-Maximilians-University University Hospital, 81377, Munich, Germany.
Celotti M; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, 3584 CT, Utrecht, the Netherlands.
van Es J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, 3584 CT, Utrecht, the Netherlands.
Lange I; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Brunner C; Department of Otorhinolaryngology, Ulm University Medical Center, 89075, Ulm, Germany.
Mircetic J; German Cancer Consortium, Partner Site Dresden: German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Mildred Scheel Early Career Center (MSNZ) P2, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.
Coppes RP; Department of Biomedical Sciences of Cells and Systems, Section of Molecular Cell Biology, University Medical Center Groningen, University of Groningen, 9713, Groningen, The Netherlands.; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, 9713, Groningen, The Netherlands.
Gires O; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany.
Dahl A; DRESDEN-Concept Genome Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, 01307, Dresden, Germany.
Seifert M; Institute for Medical Informatics and Biometry (IMB), Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), 69192, Heidelberg, Germany.
Cordes N; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, 01307, Dresden, Germany. .; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany. .; German Cancer Consortium, Partner Site Dresden: German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. .; National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), 69192, Heidelberg, Germany. .; Department of Radiotherapy and Radiation Oncology, University Hospital Carl Gustav Carus, 01307, Dresden, Germany. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Feb 21; Vol. 23 (1), pp. 39. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Antineoplastic Agents*/therapeutic use
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Integrin beta1/genetics ; Cell Line, Tumor ; Receptor Protein-Tyrosine Kinases/genetics ; ErbB Receptors/metabolism ; Phenotype ; Epithelial-Mesenchymal Transition/genetics
Czasopismo naukowe
Tytuł:
The association of HBV infection and head and neck cancer: a systematic review and meta-analysis.
Autorzy:
Tan R; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Zhu X; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Sun Y; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Yang S; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Peng C; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Feng X; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Chen Z; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China.; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China.
Yimamu Y; The First People's Hospital of Kashi Area, Xinjiang Uygur Autonomous Region, No.120, Yingbin Avenue, Kashi, People's Republic of China.
Liao G; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China. .; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China. .
Yang L; Hospital of Stomatology, Sun Yat-sen University, 56th Lingyuanxi Road, 510055, Guangzhou, Guangdong, China. .; Guangdong Province Key Laboratory of Stomatology, No. 74, 2nd Zhongshan Road, 510080, Guangzhou, Guangdong, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 16; Vol. 24 (1), pp. 225. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Hepatitis B*/complications
Hepatitis B*/epidemiology
Head and Neck Neoplasms*/etiology
Head and Neck Neoplasms*/complications
Nasopharyngeal Neoplasms*/complications
Mouth Neoplasms*
Humans ; Hepatitis B virus ; Cohort Studies ; Nasopharyngeal Carcinoma/complications
Czasopismo naukowe
Tytuł:
CTC together with Shh and Nrf2 are prospective diagnostic markers for HNSCC.
Autorzy:
Rahman MM; Rangamati Medical College, Rangamati, Bangladesh.; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Hossain MM; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh. .; EuGEF Research Foundation, Chattogram, Bangladesh. .
Islam S; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.; Present Address: Stem Cell Genetics, Institute of Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Ahmed R; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Majumder M; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Dey S; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Kawser M; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Sarkar B; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Himu MER; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Chowdhury AA; Department of Radiotherapy, Chittagong Medical College, Chattogram, Bangladesh.
Ahmed S; Department of Surgery, Chittagong Medical College, Chattogram, Bangladesh.
Biswas S; Department of Otolaryngology and Head Neck Surgery, Chittagong Medical College, Chattogram, Bangladesh.
Anwar MM; Department of Otolaryngology and Head Neck Surgery, Chittagong Medical College, Chattogram, Bangladesh.
Hussain MJ; Department of Otolaryngology and Head Neck Surgery, Rangamati Medical College, Rangamati, Bangladesh.
Kumar Shil R; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Baidya S; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Parial R; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Islam MM; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh.; EuGEF Research Foundation, Chattogram, Bangladesh.
Bharde A; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Jayant S; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Aland G; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Khandare J; Actorious Innovations and Research Pvt. Ltd., India and Simi Valley, Pune, CA, USA.
Uddin SB; Department of Botany, University of Chittagong, Chattogram, Bangladesh.
Noman ASM; Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram, 4331, Bangladesh. .; EuGEF Research Foundation, Chattogram, Bangladesh. .
Pokaż więcej
Źródło:
BMC molecular and cell biology [BMC Mol Cell Biol] 2024 Feb 10; Vol. 25 (1), pp. 4. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Journal Article
MeSH Terms:
NF-E2-Related Factor 2*
Head and Neck Neoplasms*/diagnosis
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/diagnosis ; Squamous Cell Carcinoma of Head and Neck/genetics ; Prospective Studies ; Hedgehog Proteins
Czasopismo naukowe
Tytuł:
Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma.
Autorzy:
Huang Y; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Liu H; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Liu B; Institute for Genome Engineered Animal Models of Human Diseases, Dalian Medical University, Dalian, China.
Chen X; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Li D; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Xue J; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Li N; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Zhu L; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China.
Yang L; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China.
Xiao J; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China. .; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China. .
Liu C; Department of Oral Pathology, Dalian Medical University School of Stomatology, Dalian, China. .; Academician Laboratory of Immunology and Oral Development & Regeneration, Dalian Medical University, Dalian, China. .
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2024 Feb 08; Vol. 17 (1), pp. 49. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/genetics
Head and Neck Neoplasms*/therapy
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/therapy ; Mutation ; Prognosis ; Biomarkers, Tumor/genetics ; Immunotherapy ; Epithelial-Mesenchymal Transition/genetics
Czasopismo naukowe
Tytuł:
Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells.
Autorzy:
Klieber N; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Hildebrand LS; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Faulhaber E; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Symank J; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Häck N; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Härtl A; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Fietkau R; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Distel LV; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 27, 91054 Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), 91054 Erlangen, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 06; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/radiotherapy
Papillomavirus Infections*
Squamous Cell Carcinoma of Head and Neck*/drug therapy
Squamous Cell Carcinoma of Head and Neck*/radiotherapy
Humans ; Apoptosis ; Cell Line, Tumor ; G2 Phase Cell Cycle Checkpoints ; Radiation, Ionizing ; TOR Serine-Threonine Kinases/antagonists & inhibitors ; DNA-Activated Protein Kinase/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis.
Autorzy:
Rodrigo JP; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
Sánchez-Canteli M; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain. .; Department of Otolaryngology, Hospital Universitario de Cabueñes and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011, Oviedo, Spain. .
Otero-Rosales M; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
Martínez-Camblor P; Department of Anesthesiology, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.; Faculty of Health Sciences, Universidad Autonoma de Chile, 7500912, Providencia, Chile.
Hermida-Prado F; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
García-Pedrero JM; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, 33011, Oviedo, Spain.; Ciber de Cáncer, CIBERONC, 28029, Madrid, Spain.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Feb 04; Vol. 22 (1), pp. 135. Date of Electronic Publication: 2024 Feb 04.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Immunotherapy*/methods
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Prognosis ; Survival Analysis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/analysis ; Mutation/genetics
Czasopismo naukowe
Tytuł:
Evaluating the effects of lymphoedema management strategies on functional status and health-related quality of life following treatment for head and neck cancer: Protocol for a systematic review.
Autorzy:
Mullan LJ; School of Nursing, Institute of Nursing and Health Research, Ulster University, Belfast, United Kingdom.
Blackburn NE; School of Health Sciences, Institute of Nursing and Health Research, Ulster University, Londonderry, United Kingdom.
Lorimer J; Physiotherapy Department, Cancer Centre, Belfast Health and Social Care Trust, Belfast, United Kingdom.
Semple CJ; School of Nursing, Institute of Nursing and Health Research, Ulster University, Belfast, United Kingdom.; Cancer Services, South Eastern Health and Social Care Trust, Belfast, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 02; Vol. 19 (2), pp. e0297757. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Quality of Life*
Head and Neck Neoplasms*/complications
Head and Neck Neoplasms*/therapy
Adult ; Humans ; Functional Status ; Research Design ; Systematic Reviews as Topic ; Meta-Analysis as Topic
Czasopismo naukowe
Tytuł:
Cocaine use and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
Autorzy:
Zhang M; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA.
Chen C; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Li G; Department of Head and Neck Surgery, Division of Surgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Koric A; Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, and Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Lee YA; Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, and Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Morgenstern H; Departments of Epidemiology and Environmental Health Sciences, School of Public Health and Department of Urology, Medical School, University of Michigan, Ann Arbor, Michigan, USA.
Schwartz SM; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Sturgis EM; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.
Boffetta P; Stony Brook Cancer Center, Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, New York, USA.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Hashibe M; Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, and Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Zhang ZF; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e7019.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Head and Neck Neoplasms*/epidemiology
Head and Neck Neoplasms*/etiology
Cocaine*
Humans ; Risk Factors ; Smoking/epidemiology ; Alcohol Drinking/adverse effects ; Alcohol Drinking/epidemiology ; Case-Control Studies
Czasopismo naukowe
Tytuł:
Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer.
Autorzy:
Mellor R; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, Australia.
Girgis CM; Department of Diabetes and Endocrinology, Westmead Hospital, Westmead, NSW 2145, Australia.; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.
Rodrigues A; The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW 2010, Australia.
Chen C; Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW 2148, Australia.
Cuan S; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, Australia.
Gambhir P; Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW 2148, Australia.
Perera L; Nepean Cancer Care Centre, Nepean Hospital, Kingswood, NSW 2747, Australia.
Veness M; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, Australia.; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.
Sundaresan P; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, Australia.; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.; Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW 2148, Australia.
Gao B; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW 2145, Australia.; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.; Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown, NSW 2148, Australia.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Feb 01; Vol. 31 (2), pp. 828-838. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Nasopharyngeal Neoplasms*
Diabetes Mellitus, Type 2*/complications
Head and Neck Neoplasms*/therapy
Head and Neck Neoplasms*/etiology
Diabetes Complications*/etiology
Insulins*
Humans ; Retrospective Studies ; Case-Control Studies ; Chemoradiotherapy/adverse effects
Czasopismo naukowe
Tytuł:
Erythrocyte PIG-A mutant frequencies in cancer patients receiving cisplatin.
Autorzy:
Dobrovolsky VN; Division of Genetic and Molecular Toxicology, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Jefferson, Arkansas, USA.
Atiq OT; University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute, Little Rock, Arkansas, USA.
Heflich RH; Division of Genetic and Molecular Toxicology, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Jefferson, Arkansas, USA.
Maisha M; Office of Scientific Coordination, NCTR, FDA, Jefferson, Arkansas, USA.
McKinzie PB; Division of Genetic and Molecular Toxicology, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Jefferson, Arkansas, USA.
Pearce MG; Division of Genetic and Molecular Toxicology, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Jefferson, Arkansas, USA.
Robison TW; Office of New Drugs, OII, DPTII, Center for Drug Evaluation and Research (CDER), US FDA, Silver Spring, Maryland, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6895. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms, Second Primary*
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Cisplatin/adverse effects ; Erythrocytes ; Mutagenesis
Czasopismo naukowe
Tytuł:
Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma.
Autorzy:
Routila E; Department of Life Technologies, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland. .; InFLAMES Research Flagship, University of Turku, 20014, Turku, Finland. .; FICAN West Cancer Centre, Turku, Finland. .
Mahran R; Department of Life Technologies, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.; FICAN West Cancer Centre, Turku, Finland.; Department of Chemistry, University of Turku, Henrikinkatu 2, 20500, Turku, Finland.
Salminen S; Department of Life Technologies, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.; FICAN West Cancer Centre, Turku, Finland.
Irjala H; Department for Otorhinolaryngology- Head and Neck surgery, University of Turku and Turku University Hospital, Savitehtaankatu 5, 20520, Turku, Finland.
Haapio E; Department for Otorhinolaryngology- Head and Neck surgery, University of Turku and Turku University Hospital, Savitehtaankatu 5, 20520, Turku, Finland.
Kytö E; Department for Otorhinolaryngology- Head and Neck surgery, University of Turku and Turku University Hospital, Savitehtaankatu 5, 20520, Turku, Finland.
Ventelä S; FICAN West Cancer Centre, Turku, Finland.; Department for Otorhinolaryngology- Head and Neck surgery, University of Turku and Turku University Hospital, Savitehtaankatu 5, 20520, Turku, Finland.; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Tykistökatu 6, 20520, Turku, Finland.
Petterson K; Department of Life Technologies, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
Routila J; FICAN West Cancer Centre, Turku, Finland.; Department for Otorhinolaryngology- Head and Neck surgery, University of Turku and Turku University Hospital, Savitehtaankatu 5, 20520, Turku, Finland.
Gidwani K; Department of Life Technologies, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.
Leivo J; Department of Life Technologies, University of Turku, Kiinamyllynkatu 10, 20520, Turku, Finland.; InFLAMES Research Flagship, University of Turku, 20014, Turku, Finland.; FICAN West Cancer Centre, Turku, Finland.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 10; Vol. 24 (1), pp. 443. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck ; Glycosylation ; Cell Line, Tumor ; Cytoskeletal Proteins/metabolism
Czasopismo naukowe
Tytuł:
Expression of Toll-like receptors in oral squamous cell carcinoma.
Autorzy:
Rusanen P; Department of Bacteriology and Immunology, Haartman institute, University of Helsinki, Helsinki, Finland.
Marttila E; Department of Oral and Maxillofacial Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Amatya SB; Biocenter Oulu & Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.
Hagström J; Department of Bacteriology and Immunology, Haartman institute, University of Helsinki, Helsinki, Finland.
Uittamo J; Department of Oral and Maxillofacial Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Research Unit on Acetaldehyde and Cancer, University of Helsinki, Helsinki, Finland.
Reunanen J; Biocenter Oulu & Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.
Rautemaa-Richardson R; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, NIHR Manchester Biomedical Research Centre (BRC) at the Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.; Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom.
Salo T; Department of Oral and Maxillofacial Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; HUSLAB, Department of Pathology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.; Department of Diagnostics and Oral Medicine, Institute of Dentistry, University of Oulu, Oulu, Finland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 09; Vol. 19 (4), pp. e0300437. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Mouth Neoplasms*/pathology
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck ; NF-kappa B/metabolism ; Toll-Like Receptor 4/metabolism ; Toll-Like Receptors
Czasopismo naukowe
Tytuł:
Single-cell RNA sequencing explores the evolution of the ecosystem from leukoplakia to head and neck squamous cell carcinoma.
Autorzy:
Wang H; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Guan Z; Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Zheng L; Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 06; Vol. 14 (1), pp. 8097. Date of Electronic Publication: 2024 Apr 06.
Typ publikacji:
Journal Article
MeSH Terms:
Ecosystem*
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Leukoplakia ; Sequence Analysis, RNA ; Prognosis ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
The effect of physical exercise during radiotherapy on physical performance in patients with head and neck cancer: a trial within cohorts study protocol, the vital study.
Autorzy:
Kriellaars Y; Department of Radiation Oncology, Instituut Verbeeten, Tilburg, the Netherlands.; Medifit Fysiotherapie Instituut Verbeeten, Tilburg, the Netherlands.
Vermaire JA; Department of Radiation Oncology, Instituut Verbeeten, Tilburg, the Netherlands.
Beugeling M; Department of Radiation Oncology, Instituut Verbeeten, Tilburg, the Netherlands.
Poorter R; Department of Radiation Oncology, Instituut Verbeeten, Tilburg, the Netherlands.
Drijvers J; Medifit Fysiotherapie Instituut Verbeeten, Tilburg, the Netherlands.
Speksnijder CM; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. .; Department of Oral and Maxillofacial Surgery and Special Dental Care, University Medical Center Utrecht, G05.122, 3508 GA, Utrecht, P.O. Box 85.500, The Netherlands. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 01; Vol. 24 (1), pp. 403. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Exercise*
Head and Neck Neoplasms*/radiotherapy
Humans ; Fatigue ; Physical Functional Performance ; Quality of Life ; Treatment Outcome ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCC.
Autorzy:
Wang C; Department of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, Guangzhou, 510282, Guangdong Province, China.; Department of Oncology, Shenzhen Hospital of Southern Medical University, Shenzhen, China.
Liu X; Department of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, Guangzhou, 510282, Guangdong Province, China.
Nov P; Department of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, Guangzhou, 510282, Guangdong Province, China.
Li L; Department of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, Guangzhou, 510282, Guangdong Province, China.
Li C; Department of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, Guangzhou, 510282, Guangdong Province, China.
Liao X; Department of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, Guangzhou, 510282, Guangdong Province, China.
Li L; Department of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, Guangzhou, 510282, Guangdong Province, China.
Du K; Department of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, Guangzhou, 510282, Guangdong Province, China. .
Li J; Department of Radiation Oncology, Oncology Center, Zhujiang Hospital of Southern Medical University, Guangzhou, 510282, Guangdong Province, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 31; Vol. 14 (1), pp. 7594. Date of Electronic Publication: 2024 Mar 31.
Typ publikacji:
Journal Article
MeSH Terms:
Tumor Microenvironment*/genetics
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Prognosis ; Circadian Rhythm/genetics
Czasopismo naukowe
Tytuł:
Real world clinical experience using daily intelligence-assisted online adaptive radiotherapy for head and neck cancer.
Autorzy:
Blumenfeld P; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel. .
Arbit E; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.
Den R; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.; Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, Israel.
Salhab A; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.
Falick Michaeli T; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.
Wygoda M; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.
Hillman Y; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.
Pfeffer RM; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.
Fang M; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.
Misrati Y; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.
Weizman N; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.
Feldman J; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.
Popovtzer A; Department of Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, POB 12272, 9112002, Jerusalem, Israel.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2024 Mar 30; Vol. 19 (1), pp. 43. Date of Electronic Publication: 2024 Mar 30.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/radiotherapy
Radiotherapy, Intensity-Modulated*
Radiotherapy, Image-Guided*
Humans ; Radiotherapy Planning, Computer-Assisted ; Intelligence ; Radiotherapy Dosage
Czasopismo naukowe
Tytuł:
Analysis of the effect of CCR7 on the microenvironment of mouse oral squamous cell carcinoma by single-cell RNA sequencing technology.
Autorzy:
Wang Z; Department of Oral Maxillofacial-Head and Neck Surgery, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, 117 Nanjing North Road, Heping District, Shenyang, Liaoning, 110002, People's Republic of China.
Kirkwood KL; Department of Oral Biology, School of Dental Medicine, University at Buffalo, NY, Buffalo, 14214-8006, USA.
Wang Y; Department of Oral Maxillofacial-Head and Neck Surgery, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, 117 Nanjing North Road, Heping District, Shenyang, Liaoning, 110002, People's Republic of China.
Du W; Department of Oral Maxillofacial-Head and Neck Surgery, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, 117 Nanjing North Road, Heping District, Shenyang, Liaoning, 110002, People's Republic of China.
Lin S; Department of Oral Maxillofacial-Head and Neck Surgery, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, 117 Nanjing North Road, Heping District, Shenyang, Liaoning, 110002, People's Republic of China.
Zhou W; Department of Oral Maxillofacial-Head and Neck Surgery, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, 117 Nanjing North Road, Heping District, Shenyang, Liaoning, 110002, People's Republic of China.
Yan C; Department of Oral Maxillofacial-Head and Neck Surgery, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, 117 Nanjing North Road, Heping District, Shenyang, Liaoning, 110002, People's Republic of China.
Gao J; Department of Oral Maxillofacial-Head and Neck Surgery, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, 117 Nanjing North Road, Heping District, Shenyang, Liaoning, 110002, People's Republic of China.
Li Z; Department of Oral Maxillofacial-Head and Neck Surgery, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, 117 Nanjing North Road, Heping District, Shenyang, Liaoning, 110002, People's Republic of China.
Sun C; Department of Oral Maxillofacial-Head and Neck Surgery, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, 117 Nanjing North Road, Heping District, Shenyang, Liaoning, 110002, People's Republic of China.
Liu F; Department of Oral Maxillofacial-Head and Neck Surgery, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, 117 Nanjing North Road, Heping District, Shenyang, Liaoning, 110002, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 27; Vol. 43 (1), pp. 94. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*
Mouth Neoplasms*/pathology
Animals ; Mice ; Cell Line, Tumor ; Endothelial Cells/metabolism ; Receptors, CCR7/genetics ; Sequence Analysis, RNA ; Squamous Cell Carcinoma of Head and Neck ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
The effects of Phoniatric PREhabilitation in Head and Neck Cancer patients on Aspiration and Preservation of Swallowing (PREHAPS): study protocol of a monocentric prospective randomized interventional outcome-blinded trial.
Autorzy:
Kuenzel J; Department of Otorhinolaryngology, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany. .
Duerr S; Department of Otorhinolaryngology, Section Phoniatrics and Pediatric Audiology, University Hospital Regensburg, Regensburg, Germany.
Vester S; Department of Otorhinolaryngology, Section Phoniatrics and Pediatric Audiology, University Hospital Regensburg, Regensburg, Germany.
Zeman F; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Huppertz G; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Koller M; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Pfleger G; Department of Otorhinolaryngology, Section Phoniatrics and Pediatric Audiology, University Hospital Regensburg, Regensburg, Germany.
Woertgen A; Department of Otorhinolaryngology, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany.
Salloum H; Department of Otorhinolaryngology, Section Phoniatrics and Pediatric Audiology, University Hospital Regensburg, Regensburg, Germany.
Klinkhammer-Schalke M; Institute for Quality Management and Health Services Research, University Hospital Regensburg, Regensburg, Germany.
Pukrop T; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
Kummer P; Department of Otorhinolaryngology, Section Phoniatrics and Pediatric Audiology, University Hospital Regensburg, Regensburg, Germany.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 22; Vol. 25 (1), pp. 211. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Head and Neck Neoplasms*/surgery
Deglutition Disorders*/diagnosis
Deglutition Disorders*/etiology
Deglutition Disorders*/prevention & control
Humans ; Deglutition ; Squamous Cell Carcinoma of Head and Neck ; Preoperative Exercise ; Quality of Life ; Prospective Studies ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Development of a communication platform for patients with head and neck cancer for effective information delivery and improvement of doctor-patient relationship: application of treatment journey-based service blueprint.
Autorzy:
Koo YR; Department of Service Design, Graduate School of Industrial Arts, Hongik University, Seoul, 04066, Korea.
Kim EJ; Department of Industry-Academic Cooperation Foundation, The Catholic University of Korea, Seoul, 06591, Korea.
Nam IC; Department of Otorhinolaryngology-Head and Neck Surgery, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, 21431, Korea. .
Pokaż więcej
Źródło:
BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2024 Mar 20; Vol. 24 (1), pp. 81. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Physician-Patient Relations*
Head and Neck Neoplasms*/therapy
Humans ; Communication ; Focus Groups ; Patients
Czasopismo naukowe
Tytuł:
Factors associated with recurrence in patients with oral cancer in Mongolia.
Autorzy:
Davaatsend O; Department of Maxillofacial Surgery, School of Dentistry, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Altannamar M; Department of Maxillofacial Surgery, School of Dentistry, Ach Medical University, Ulaanbaatar, Mongolia.
Ganbat M; Department of Epidemiology and Biostatistics, School of Public Health, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Jagdagsuren U; Department of Restorative Dentistry, School of Dentistry, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 20; Vol. 24 (1), pp. 356. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Mouth Neoplasms*/epidemiology
Mouth Neoplasms*/therapy
Mouth Neoplasms*/pathology
Head and Neck Neoplasms*/pathology
Male ; Humans ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Mongolia/epidemiology ; Neoplasm Staging ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Tytuł:
Tumor-infiltrating immune cells and survival in head and neck squamous cell carcinoma: a retrospective computational study.
Autorzy:
Zhang L; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, People's Republic of China.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, 110 Xiangya Road, Changsha, 410078, People's Republic of China.; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha, 410078, People's Republic of China.; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha, 410008, Hunan, People's Republic of China.
Wang WQ; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, People's Republic of China.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, 110 Xiangya Road, Changsha, 410078, People's Republic of China.; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha, 410078, People's Republic of China.; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha, 410008, Hunan, People's Republic of China.
Chen JH; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, People's Republic of China.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, 110 Xiangya Road, Changsha, 410078, People's Republic of China.; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha, 410078, People's Republic of China.; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha, 410008, Hunan, People's Republic of China.
Feng J; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, People's Republic of China.; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, 110 Xiangya Road, Changsha, 410078, People's Republic of China.; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha, 410078, People's Republic of China.; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha, 410008, Hunan, People's Republic of China.
Liao YZ; Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, People's Republic of China.
Zou Y; High Performance Computing Center, Central South University, Changsha, 410008, People's Republic of China. .
Liu R; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, People's Republic of China. .; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, 110 Xiangya Road, Changsha, 410078, People's Republic of China. .; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha, 410078, People's Republic of China. .; National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha, 410008, Hunan, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 16; Vol. 14 (1), pp. 6390. Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck ; Retrospective Studies ; Prognosis ; CD8-Positive T-Lymphocytes ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Polygenic risk score-based phenome-wide association study of head and neck cancer across two large biobanks.
Autorzy:
Lee YC; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Jung SH; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Shivakumar M; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Cha S; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Park WY; Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Won HH; Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Samsung Medical Center, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.
Eun YG; Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Biobank PM; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kim D; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. .; Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA, USA. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Mar 14; Vol. 22 (1), pp. 120. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Genome-Wide Association Study*/methods
Head and Neck Neoplasms*/genetics
Humans ; Genetic Risk Score ; Squamous Cell Carcinoma of Head and Neck/genetics ; Biological Specimen Banks ; Genetic Predisposition to Disease
Czasopismo naukowe
Tytuł:
Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis.
Autorzy:
Qi L; Hunan Key Laboratory of Oral Health Research, Hunan Clinical Research Center of Oral Major Diseases and Oral Health, Xiangya Stomatological Hospital, Xiangya School of Stomatology, Central South University, Changsha, 410000, China.
Tang Z; Hunan Key Laboratory of Oral Health Research, Hunan Clinical Research Center of Oral Major Diseases and Oral Health, Xiangya Stomatological Hospital, Xiangya School of Stomatology, Central South University, Changsha, 410000, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6149. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/genetics
Mouth Neoplasms*/genetics
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Prognosis ; Pyroptosis/genetics ; Computational Biology
Czasopismo naukowe
Tytuł:
Parotid glands have a dysregulated immune response following radiation therapy.
Autorzy:
Gunning JA; Department of Nutritional Sciences, The University of Arizona, Tucson, Arizona, United States of America.
Gilman KE; Department of Nutritional Sciences, The University of Arizona, Tucson, Arizona, United States of America.
Zúñiga TM; Department of Nutritional Sciences, The University of Arizona, Tucson, Arizona, United States of America.; Department of Immunology and Microbiology, Aurora, Colorado, United States of America.
Simpson RJ; Department of Nutritional Sciences, The University of Arizona, Tucson, Arizona, United States of America.
Limesand KH; Department of Nutritional Sciences, The University of Arizona, Tucson, Arizona, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 12; Vol. 19 (3), pp. e0297387. Date of Electronic Publication: 2024 Mar 12 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Parotid Gland*/radiation effects
Head and Neck Neoplasms*
Mice ; Animals ; Insulin-Like Growth Factor I ; Salivary Glands ; Immunity
Czasopismo naukowe
Tytuł:
High incidence of HPV infection in minors with oral squamous cell carcinoma.
Autorzy:
Wu N; The Affiliated Stomatological Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.; Jiangxi Province Key Laboratory of Oral Biomedicine, Nanchang, China.; Jiangxi Province Clinical Research Center for Oral Diseases, Nanchang, China.
Li Y; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
Ma X; Department of Oral and Maxillofacial Surgery, The Affiliated Stomatological Hospital of Soochow University, Suzhou Stomatological Hospital, Suzhou, China.
Huang Z; College of Life Sciences, Fujian Normal University, Fuzhou, China.
Chen Z; The Affiliated Stomatological Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.; Jiangxi Province Key Laboratory of Oral Biomedicine, Nanchang, China.; Jiangxi Province Clinical Research Center for Oral Diseases, Nanchang, China.
Chen W; The Affiliated Stomatological Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.; Jiangxi Province Key Laboratory of Oral Biomedicine, Nanchang, China.; Jiangxi Province Clinical Research Center for Oral Diseases, Nanchang, China.
Zhang R; Department of Oral Pathology, Peking University School and Hospital of Stomatology, 22 South Zhongguancun Avenue, Haidian District, Beijing, 100081, China. .; Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences, Beijing, China. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2024 Mar 09; Vol. 19 (1), pp. 51. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Mouth Neoplasms*/pathology
Papillomavirus Infections*/complications
Papillomavirus Infections*/epidemiology
Head and Neck Neoplasms*
Humans ; Aged ; Squamous Cell Carcinoma of Head and Neck ; Incidence ; Papillomaviridae/genetics ; DNA, Viral/genetics ; Cyclin-Dependent Kinase Inhibitor p16/genetics
Czasopismo naukowe
Tytuł:
Multimodal artificial intelligence-based pathogenomics improves survival prediction in oral squamous cell carcinoma.
Autorzy:
Vollmer A; Department of Oral and Maxillofacial Plastic Surgery, University Hospital of Würzburg, 97070, Würzburg, Franconia, Germany. Vollmer_.
Hartmann S; Department of Oral and Maxillofacial Plastic Surgery, University Hospital of Würzburg, 97070, Würzburg, Franconia, Germany.
Vollmer M; Department of Oral and Maxillofacial Surgery, Tuebingen University Hospital, Osianderstrasse 2-8, 72076, Tuebingen, Germany.
Shavlokhova V; Maxillofacial Surgery University Hospital Ruppin-Brandenburg, Fehrbelliner Straße 38, 16816, Neuruppin, Germany.
Brands RC; Department of Oral and Maxillofacial Plastic Surgery, University Hospital of Würzburg, 97070, Würzburg, Franconia, Germany.
Kübler A; Department of Oral and Maxillofacial Plastic Surgery, University Hospital of Würzburg, 97070, Würzburg, Franconia, Germany.
Wollborn J; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Hassel F; Department of Spine Surgery, Loretto Hospital, Freiburg, Germany.
Couillard-Despres S; Institute of Experimental Neuroregeneration, Paracelsus Medical University, 5020, Salzburg, Austria.; Austrian Cluster for Tissue Regeneration, Vienna, Austria.
Lang G; Department of Orthopedics and Trauma Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Saravi B; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.; Department of Spine Surgery, Loretto Hospital, Freiburg, Germany.; Institute of Experimental Neuroregeneration, Paracelsus Medical University, 5020, Salzburg, Austria.; Department of Orthopedics and Trauma Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5687. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/genetics
Mouth Neoplasms*/genetics
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Artificial Intelligence
Czasopismo naukowe
Tytuł:
Consideration of image guidance in patterns of failure analyses of intensity-modulated radiotherapy for head and neck cancer: a systematic review.
Autorzy:
Mackeprang PH; Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, 3010, Bern, Switzerland. .; Division of Medical Radiation Physics, Inselspital, Bern University Hospital and University of Bern, 3010, Bern, Switzerland. .
Bryjova K; Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, 3010, Bern, Switzerland.
Heusel AE; Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, 3010, Bern, Switzerland.
Henzen D; Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, 3010, Bern, Switzerland.; Division of Medical Radiation Physics, Inselspital, Bern University Hospital and University of Bern, 3010, Bern, Switzerland.
Scricciolo M; Radiation Oncology Division, Clinical Radiology Department, Ospedale dell'Angelo, Via Paccagnella 11, 30174, Venezia, Italy.
Elicin O; Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, 3010, Bern, Switzerland.
Pokaż więcej
Corporate Authors:
EORTC Head & Neck Young Investigators Group
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2024 Mar 05; Vol. 19 (1), pp. 30. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Radiotherapy, Intensity-Modulated*
Nasopharyngeal Neoplasms*
Head and Neck Neoplasms*/radiotherapy
Humans ; Squamous Cell Carcinoma of Head and Neck ; Prospective Studies
Czasopismo naukowe
Tytuł:
KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma.
Autorzy:
Cai H; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology,, Sun Yat-Sen University, Guangzhou, 51055, China.; Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510080, China.
Liang J; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology,, Sun Yat-Sen University, Guangzhou, 51055, China.; Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510080, China.
Jiang Y; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology,, Sun Yat-Sen University, Guangzhou, 51055, China.; Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510080, China.
Wang Z; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology,, Sun Yat-Sen University, Guangzhou, 51055, China.; Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510080, China.
Li H; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology,, Sun Yat-Sen University, Guangzhou, 51055, China.; Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510080, China.
Wang W; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology,, Sun Yat-Sen University, Guangzhou, 51055, China.; Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510080, China.
Wang C; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology,, Sun Yat-Sen University, Guangzhou, 51055, China. .; Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510080, China. .
Hou J; Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Guanghua School of Stomatology,, Sun Yat-Sen University, Guangzhou, 51055, China. .; Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, 510080, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 05; Vol. 43 (1), pp. 69. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Nuclear Proteins*
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Transcription Factors ; Oncogenes ; Kruppel-Like Transcription Factors/genetics ; RNA-Binding Proteins ; Bromodomain Containing Proteins ; Cell Cycle Proteins
Czasopismo naukowe
Tytuł:
A preliminary study of IgG4 expression and its prognostic significance in oral squamous cell carcinoma.
Autorzy:
Fukuda H; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Uehara T; Department of Laboratory Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, 390-8621, Matsumoto, Nagano, Japan. .
Nakajima T; Department of Laboratory Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, 390-8621, Matsumoto, Nagano, Japan.
Iwaya M; Department of Laboratory Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, 390-8621, Matsumoto, Nagano, Japan.
Asaka S; Department of Laboratory Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, 390-8621, Matsumoto, Nagano, Japan.; Department of Laboratory Medicine, Nagano Children's Hospital, Azumino, Japan.
Kurita H; Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 04; Vol. 24 (1), pp. 294. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*
Mouth Neoplasms*
Tongue Neoplasms*
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck ; Prognosis ; Immunoglobulin G
Czasopismo naukowe
Tytuł:
ITGAV Promotes the Progression of Head and Neck Squamous Cell Carcinoma.
Autorzy:
Xu L; School of Dentistry, University of California, Los Angeles, CA 90095, USA.
Barrett JG; School of Dentistry, University of California, Los Angeles, CA 90095, USA.
Peng J; School of Dentistry, University of California, Los Angeles, CA 90095, USA.
Li S; School of Dentistry, University of California, Los Angeles, CA 90095, USA.
Messadi D; School of Dentistry, University of California, Los Angeles, CA 90095, USA.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90024, USA.
Hu S; School of Dentistry, University of California, Los Angeles, CA 90095, USA.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90024, USA.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Mar 01; Vol. 31 (3), pp. 1311-1322. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*
Carcinoma, Squamous Cell*/pathology
Humans ; Squamous Cell Carcinoma of Head and Neck ; Integrin alphaV ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Notch signaling genes and CD8 T-cell dynamics: Their contribution to immune-checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study.
Autorzy:
Ogi K; Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Iwamoto T; Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Sasaya T; Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Nishiyama K; Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Tokura T; Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Sasaki T; Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Dehari H; Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Arihara Y; Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Murase K; Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Saito M; Department of Radiology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Someya M; Department of Radiology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Takada K; Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Miyazaki A; Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e6985.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/metabolism
Mouth Neoplasms*/drug therapy
Mouth Neoplasms*/genetics
Mouth Neoplasms*/metabolism
Head and Neck Neoplasms*/pathology
Humans ; Squamous Cell Carcinoma of Head and Neck/pathology ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/metabolism ; Retrospective Studies ; B7-H1 Antigen/metabolism ; CD8-Positive T-Lymphocytes
Czasopismo naukowe
Tytuł:
Prediction of prognosis in oral squamous cell carcinoma using infrared microspectroscopy.
Autorzy:
Whitley CA; Department of Physics, University of Liverpool, Liverpool, UK.
Ellis BG; Department of Physics, University of Liverpool, Liverpool, UK.
Triantafyllou A; Department of Pathology, Liverpool Clinical Laboratories, University of Liverpool, Liverpool, UK.
Gunning PJ; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Gardner P; Department of Chemical Engineering, The University of Manchester, Manchester, UK.
Barrett SD; Department of Physics, University of Liverpool, Liverpool, UK.
Shaw RJ; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.; Regional Maxillofacial Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Smith CI; Department of Physics, University of Liverpool, Liverpool, UK.
Weightman P; Department of Physics, University of Liverpool, Liverpool, UK.
Risk JM; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7094.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Mouth Neoplasms*/pathology
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck ; Prognosis
Czasopismo naukowe
Tytuł:
From planned neck dissection to PET response to circulating tumour DNA: changes in post-treatment assessment of HPV-driven oropharyngeal cancer .
Autorzy:
Post CM; Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon, USA.
Ohaegbulam KC; Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon, USA.
Mitin T; Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon, USA.
Pokaż więcej
Źródło:
Journal of medical radiation sciences [J Med Radiat Sci] 2024 Mar; Vol. 71 (1), pp. 21-25. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:
Journal Article
MeSH Terms:
Circulating Tumor DNA*
Papillomavirus Infections*/diagnosis
Papillomavirus Infections*/surgery
Carcinoma, Squamous Cell*
Oropharyngeal Neoplasms*/diagnostic imaging
Oropharyngeal Neoplasms*/therapy
Head and Neck Neoplasms*
Humans ; Positron Emission Tomography Computed Tomography/methods ; Neck Dissection ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Situational anxiety in head and neck cancer: Rates, patterns and clinical management interventions in a regional cancer setting.
Autorzy:
Forbes E; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Clover K; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; PsychoOncology Service, Department of Consultation Liaison Psychiatry, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Oultram S; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Radiation Oncology Department, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Wratten C; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Radiation Oncology Department, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Kumar M; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Radiation Oncology Department, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Tieu MT; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Radiation Oncology Department, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
Carter G; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Department of Consultation Liaison Psychiatry, Calvary Mater Newcastle, Waratah, New South Wales, Australia.
McCarter K; School of Psychological Sciences, College of Science, Engineering and Environment, University of Newcastle, Callaghan, New South Wales, Australia.
Britton B; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Hunter New England Mental Health Services, Newcastle, New South Wales, Australia.
Baker AL; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Pokaż więcej
Źródło:
Journal of medical radiation sciences [J Med Radiat Sci] 2024 Mar; Vol. 71 (1), pp. 100-109. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Anxiety Agents*
Head and Neck Neoplasms*/radiotherapy
Humans ; Anxiety/epidemiology ; Anxiety/therapy ; Patients ; Australia
Czasopismo naukowe
Tytuł:
Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives.
Autorzy:
Khoo A; Department of Otolaryngology, Head & Neck Surgery, Canberra Health Services, Canberra, ACT 2601, Australia.
Boyer M; Chris O'Brien Lifehouse, Camperdown, NSW 2050, Australia.
Jafri Z; Vascular Biology and Translational Research, Department of Pathology, School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.
Makeham T; Department of Otolaryngology, Head & Neck Surgery, Canberra Health Services, Canberra, ACT 2601, Australia.; ANU School of Medicine & Psychology, Australian National University, Canberra, ACT 0200, Australia.
Pham T; Department of Otolaryngology, Head & Neck Surgery, Canberra Health Services, Canberra, ACT 2601, Australia.; ANU School of Medicine & Psychology, Australian National University, Canberra, ACT 0200, Australia.
Khachigian LM; Vascular Biology and Translational Research, Department of Pathology, School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.
Floros P; St Vincent's Hospital, 390 Victoria Street, Sydney, NSW 2010, Australia.
Dowling E; Department of Otolaryngology, Head & Neck Surgery, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.
Fedder K; Department of Otolaryngology, Head & Neck Surgery, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.
Shonka D Jr; Department of Otolaryngology, Head & Neck Surgery, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.
Garneau J; Department of Otolaryngology, Head & Neck Surgery, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.
O'Meara CH; Department of Otolaryngology, Head & Neck Surgery, Canberra Health Services, Canberra, ACT 2601, Australia.; ANU School of Medicine & Psychology, Australian National University, Canberra, ACT 0200, Australia.; Department of Otolaryngology, Head & Neck Surgery, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 28; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Head and Neck Neoplasms*
Oropharyngeal Neoplasms*/pathology
Papillomavirus Infections*
Humans ; Squamous Cell Carcinoma of Head and Neck ; Immune System/pathology ; Human Papillomavirus Viruses ; Immunotherapy ; Papillomaviridae
Czasopismo naukowe
Tytuł:
The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC).
Autorzy:
Wang CW; Institute of Biomedical Sciences, National Chung Hsing University, Taichung 40227, Taiwan.; Department of Otorhinolaryngology-Head and Neck Surgery, Changhua Christian Hospital, Changhua 50006, Taiwan.
Biswas PK; Institute of Molecular Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
Islam A; Institute of Biomedical Sciences, National Chung Hsing University, Taichung 40227, Taiwan.
Chen MK; Department of Otorhinolaryngology-Head and Neck Surgery, Changhua Christian Hospital, Changhua 50006, Taiwan.
Chueh PJ; Institute of Biomedical Sciences, National Chung Hsing University, Taichung 40227, Taiwan.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 27; Vol. 13 (5). Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Head and Neck Neoplasms*
Carcinoma, Squamous Cell*/etiology
Humans ; Squamous Cell Carcinoma of Head and Neck ; Immune Checkpoint Inhibitors ; Immunotherapy/adverse effects
Czasopismo naukowe
Tytuł:
Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma.
Autorzy:
Liang S; Department of Oral Medicine, Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China.
Ji L; Department of Oral Medicine, Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China.
Yu Z; Department of Oral Medicine, Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China.
Cheng Y; Department of Physiology, School of Medicine, China Medical University, Taichung, 40402, Taiwan.
Gao R; Department of Oral Medicine, Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China.
Yan W; Department of Oral Medicine, Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China.
Zhang F; Department of Oral Medicine, Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, 030001, China. .
Pokaż więcej
Źródło:
Hereditas [Hereditas] 2024 Feb 27; Vol. 161 (1), pp. 10. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/therapy
RNA, Long Noncoding*/genetics
Mouth Neoplasms*/genetics
Mouth Neoplasms*/therapy
Head and Neck Neoplasms*
Humans ; Squamous Cell Carcinoma of Head and Neck ; Epigenesis, Genetic ; Reproducibility of Results ; Prognosis ; Biomarkers ; Immunotherapy ; Computational Biology ; Apoptosis
Czasopismo naukowe
Tytuł:
Elucidating Hedgehog pathway's role in HNSCC progression: insights from a 6-gene signature.
Autorzy:
Yang Y; Department of Oncology, The Third People's Hospital of Chengdu, Chengdu, 610014, China.
Yang C; Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610042, China.
Yang Q; Military Casualty Management Department, General Hospital of the Western War Zone of the Chinese People's Liberation Army, Chengdu, 610036, China.
Lu S; Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610042, China.
Liu B; Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610042, China.
Li D; Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610042, China.
Li D; Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610042, China.
Zhang P; Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610042, China.
Xu P; Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610042, China.
Lang J; Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610042, China.
Zhou J; Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610042, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 26; Vol. 14 (1), pp. 4686. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Hedgehog Proteins*/genetics
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/genetics ; Algorithms ; Ephrin-B2 ; Prognosis ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
Extracting interpretable features for pathologists using weakly supervised learning to predict p16 expression in oropharyngeal cancer.
Autorzy:
Adachi M; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.; Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.
Taki T; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Sakamoto N; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.; Division of Pathology, National Cancer Center Exploratory Oncology Research and Clinical Trial Center, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Kojima M; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.; Division of Pathology, National Cancer Center Exploratory Oncology Research and Clinical Trial Center, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Hirao A; Division of Pathology, National Cancer Center Exploratory Oncology Research and Clinical Trial Center, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Matsuura K; Department of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Hayashi R; Department of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Tabuchi K; Department of Otolaryngology, Head and Neck Surgery, University of Tsukuba, Tsukuba, Japan.
Ishikawa S; Division of Pathology, National Cancer Center Exploratory Oncology Research and Clinical Trial Center, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.; Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Ishii G; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.; Division of Innovative Pathology and Laboratory Medicine, National Cancer Center Exploratory Oncology Research and Clinical Trial Center, Kashiwa, Japan.
Sakashita S; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan. .; Division of Pathology, National Cancer Center Exploratory Oncology Research and Clinical Trial Center, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 24; Vol. 14 (1), pp. 4506. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Oropharyngeal Neoplasms*/pathology
Head and Neck Neoplasms*
Humans ; Artificial Intelligence ; Pathologists ; Squamous Cell Carcinoma of Head and Neck ; Supervised Machine Learning
Czasopismo naukowe
Tytuł:
ALMS1-IT1 : A Key Player in the Novel Disulfidptosis-Related LncRNA Prognostic Signature for Head and Neck Squamous Cell Carcinoma.
Autorzy:
Sun XY; Central Laboratory, Peking University School and Hospital of Stomatology, Beijing 100081, China.; National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing 100081, China.; Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China.; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Xiao M; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Fu M; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Gao Q; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Li RF; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Wang J; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Li SL; Central Laboratory, Peking University School and Hospital of Stomatology, Beijing 100081, China.; National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing 100081, China.; Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China.; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Ge XY; Central Laboratory, Peking University School and Hospital of Stomatology, Beijing 100081, China.; National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing 100081, China.; Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China.; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Feb 23; Vol. 14 (3). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
RNA, Long Noncoding*/genetics
Head and Neck Neoplasms*/genetics
Humans ; Prognosis ; NADP ; Squamous Cell Carcinoma of Head and Neck/genetics ; Disulfides ; Cell Cycle Proteins
Czasopismo naukowe
Tytuł:
Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review.
Autorzy:
Bastías D; Unit of Oral Pathology and Oral Medicine, Faculty of Dentistry, Universidad Andres Bello, Viña del Mar 2520000, Chile.
Maturana A; Unit of Oral Pathology and Oral Medicine, Faculty of Dentistry, Universidad Andres Bello, Viña del Mar 2520000, Chile.
Marín C; Unit of Oral Pathology and Oral Medicine, Faculty of Dentistry, Universidad Andres Bello, Viña del Mar 2520000, Chile.
Martínez R; Unit of Oral Pathology and Oral Medicine, Faculty of Dentistry, Universidad Andres Bello, Viña del Mar 2520000, Chile.
Niklander SE; Unit of Oral Pathology and Oral Medicine, Faculty of Dentistry, Universidad Andres Bello, Viña del Mar 2520000, Chile.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 23; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Mouth Neoplasms*/pathology
Carcinoma, Squamous Cell*/pathology
Precancerous Conditions*
Head and Neck Neoplasms*
Humans ; Matrix Metalloproteinase 9 ; Biomarkers, Tumor ; Interleukin-8 ; Tumor Necrosis Factor-alpha ; Interleukin-6 ; Biomarkers ; Squamous Cell Carcinoma of Head and Neck ; Saliva ; Interleukin-1beta
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies